HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- June 2025: This Month in Huntington’s Disease Research
- Trouble on the Block: When the Neighborhood Loses Its Best Firefighter
- The latest volume of HD genetics research reveals new gems but also mysteries
- When a Short Fuse Becomes a Storm: Understanding Irritability in Huntington’s Disease
- Full Steam Ahead: uniQure’s On Track With Hope for Accelerated Approval of Huntington’s Disease Drug
Literature
- In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease
- Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
- Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment
- Huntington disease and Beta-blocker drug use
- The Retinal Dopaminergic Circuit as a Biomarker for Huntington's and Alzheimer's Diseases
News
- LIVE! Daily News | Young Life Lost to Juvenile Huntington's Disease - San Angelo LIVE!
- Sage to lay off most staff amid Supernus buyout | BioPharma Dive
- Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP ...
- GoFundMe Set Up for Local Girl Who Passed Away from JHD - San Angelo LIVE!
- Neurocrine Launches First Human Trial for Novel Long-Acting CAH Treatment | NBIX Stock News